Retail Offer for up to £5.0 million

THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF CREO MEDICAL GROUP PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY BY SUCH PERSONS.

Creo Medical Group plc

("Creo" or the "Company")

Retail Offer for up to £5.0 million

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy for cancer and pre-cancer patients, is pleased to announce a retail offer via the BookBuild Platform to raise up to £5.0 million (the "Retail Offer") through the issue of new ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares").

Under the Retail Offer, up to 20,833,333 new Ordinary Shares (the "Retail Offer Shares") will be made available at a price of 24 pence per Ordinary Share (the "Issue Price").

In addition to the Retail Offer, and as announced by the Company earlier today (the "Launch Announcement"), the Company is also proposing a placing of new Ordinary Shares (the "Placing Shares") to raise a minimum of £12 million (before expenses) (the "Placing") at the Issue Price. The Launch Announcement sets out the terms of the Placing together with the reasons for the Placing and the use of proceeds. The proceeds of the Retail Offer will be utilised to provide further balance sheet strength for future growth as the Company continues to roll out its defined med-tech strategy.

The Issue Price represents a discount of approximately 10.3 per cent to the closing share price of 26.75 pence per existing Ordinary Share on 27 September 2024.

The Retail Offer is conditional on the Placing Shares and the Retail Offer Shares being admitted to trading on the AIM market ("AIM") operated by London Stock Exchange ("Admission"). The issue of the Placing Shares and the Retail Offer Shares remains subject to the passing of certain resolutions ("Resolutions") at a general meeting of the Company to be held at 10.00 a.m. on 18 October 2024.

It is anticipated that Admission will become effective and that dealings in the Placing Shares and the Retail Offer Shares will commence on AIM, at 8.00 a.m. on 21 October 2024.

Expected Timetable in relation to the Retail Offer

Retail Offer

The Company is therefore making the Retail Offer available in the United Kingdom through the financial intermediaries which will be listed, subject to certain access restrictions, on the following website:

The Retail Offer will be open to eligible investors in the United Kingdom at 3:50 p.m. on 30 September 2024. The Retail Offer is expected to close at 4:30 p.m. on 7 October 2024. Investors should note that financial intermediaries may have earlier closing times. The Retail Offer may close early if it is oversubscribed.

There is a minimum subscription of £100.00 per investor under the terms of the Retail Offer which is open to investors in the United Kingdom subscribing via the intermediaries which will be listed, subject to certain access restrictions, on the following website: